The U.S. Court of Appeals for the Second Circuit has resurrected a class action lawsuit filed by Pfizer Inc. shareholders who allege the drug maker misled them about certain pain-relieving drugs and, in turn, cost them billions. In its April 12 decision, the federal appeals court vacated the judgment of the U.S. District Court for the Southern District of New …